Comparison of rifabutin susceptibility and rpoB mutations in multi-drug-resistant Mycobacterium tuberculosis strains by DNA sequencing and the line probe assay

被引:18
|
作者
Yoshida, Shiomi [1 ]
Suzuki, Katsuhiro [1 ]
Iwamoto, Tomotada [3 ]
Tsuyuguchi, Kazunari [1 ]
Tomita, Motohisa [2 ]
Okada, Masaji [1 ]
Sakatani, Mitsunori [4 ]
机构
[1] Natl Hosp Org, Clin Res Ctr, Kinki Chuo Chest Med Ctr, Sakai, Osaka 5918555, Japan
[2] Natl Hosp Org, Dept Clin Microbiol, Kinki Chuo Chest Med Ctr, Sakai, Osaka 5918555, Japan
[3] Kobe Inst Hlth, Dept Microbiol, Chuo Ku, Kobe, Hyogo 6500046, Japan
[4] Natl Hosp Org, Dept Resp Med, Kinki Chuo Chest Med Ctr, Kita Ku, Sakai, Osaka 5918555, Japan
关键词
Tuberculosis; Drug resistance; Rifabutin; rpoB; Line probe assay; RIFAMYCIN CROSS-RESISTANCE; IN-VITRO ACTIVITY; RIFAMPICIN; COMPLEX;
D O I
10.1007/s10156-010-0057-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We compared rifabutin susceptibility and rpoB mutations in 98 multi-drug-resistant strains of Mycobacterium tuberculosis (MDR-TB) by DNA sequencing and with a line probe assay using the commercially available INNO-LiPA Rif. TB kit (the LiPA). Our results indicated that rifabutin continues to remain active against MDR-TB strains harboring certain genetic alterations and also that the LiPA might be useful in identifying MDR-TB strains susceptible to rifabutin.
引用
收藏
页码:360 / 363
页数:4
相关论文
共 50 条
  • [31] The Structural Basis of Mycobacterium tuberculosis RpoB Drug-Resistant Clinical Mutations on Rifampicin Drug Binding
    Amusengeri, Arnold
    Khan, Asifullah
    Tastan Bishop, Oezlem
    MOLECULES, 2022, 27 (03):
  • [32] Characterization of mutations in rpoB gene associated with drug resistance in Mycobacterium tuberculosis strains from Pakistan
    Yasmin, Mamoona
    Mujtaba, Nosheen
    Haider, Fida
    Perveen, Saima
    Siddiqui, Rubina Tabassum
    CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S109 - S109
  • [33] rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis strains isolated in the Aegean region of Turkey
    Oguz, VA
    Eroglu, C
    Guneri, S
    Yapar, N
    Oztop, A
    Sanic, A
    Yuce, A
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (05) : 442 - 445
  • [34] DIHYDROSPHINGOSINE RELATED COMPOUNDS HIGHLY ACTIVE AGAINST MULTI-DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS
    del Olmo, Esther
    Bustos, Luis A.
    Lopez-Perez, Jose L.
    Molina-Salinas, Gloria M.
    Said-Fernandez, Salvador
    San Feliciano, Arturo
    DRUGS OF THE FUTURE, 2009, 34 : 181 - 181
  • [35] Development of DNA Bio-chip for Detection of Mutations of rpoB, embB and inhA Genes in Drug-Resistant Mycobacterium Tuberculosis
    Bharti Jain
    Savita Kulkarni
    Indian Journal of Clinical Biochemistry, 2023, 38 : 242 - 250
  • [36] Existence of multiple-stable equilibria for a multi-drug-resistant model of mycobacterium tuberculosis
    Gumel, Abba B.
    Song, Baojun
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2008, 5 (03) : 437 - 455
  • [37] Development of DNA Bio-chip for Detection of Mutations of rpoB, embB and inhA Genes in Drug-Resistant Mycobacterium Tuberculosis
    Jain, Bharti
    Kulkarni, Savita
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2023, 38 (02) : 242 - 250
  • [38] Rifampin resistance missed in phenotypic drug susceptibility testing for Mycobacterium tuberculosis isolates with disputed rpoB mutations
    Huh, H. J.
    Koh, W-J.
    Song, D. J.
    Ki, C-S.
    Lee, N. Y.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 45 : S123 - S123
  • [39] Robustness of the Line Probe Assay for the Rapid Diagnosis and Characterization of Mutations in Extensively Drug-Resistant Tuberculosis
    Ninan, Marilyn M.
    Rupali, Priscilla
    James, Prince
    Michael, Joy S.
    MICROBIAL DRUG RESISTANCE, 2019, 25 (06) : 799 - 804
  • [40] The Utility of Line Probe Assay in Early Diagnosis and Treatment of Multi Drug Resistant Tuberculosis in Baluchistan
    Hamza, Amir
    Ahmed, Khalil
    Ahmed, Maqbool
    Bakhsh, Amir
    Mengal, Muhammad Zahid
    Durrani, Abdul Baqi
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2020, 14 (03): : 880 - 883